INIM Pharma Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Investors
  • 1

INIM Pharma General Information

Description

Developer of inhaled immunomodulatory drugs designed to treat idiopathic pulmonary fibrosis and severe pulmonary sarcoidosis. The company develops drugs for the local treatment of interstitial lung diseases., providing medical professionals and healthcare institutions with access to effective and enhanced treatments for deadly diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Sweden
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Vicore Pharma Holding
Vertical(s)
Life Sciences
Corporate Office
  • Sweden

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

INIM Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 20-Aug-2018 Completed Startup
2. Corporate 16-May-2018 Completed Startup
1. Early Stage VC 24-Apr-2018 Completed Startup
To view INIM Pharma’s complete valuation and funding history, request access »

INIM Pharma Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Nanologica Corporation Minority
To view INIM Pharma’s complete investors history, request access »

Ready to get started?

Request a free trial

INIM Pharma FAQs

  • When was INIM Pharma founded?

    INIM Pharma was founded in 2018.

  • Where is INIM Pharma headquartered?

    INIM Pharma is headquartered in Sweden.

  • What industry is INIM Pharma in?

    INIM Pharma’s primary industry is Drug Discovery.

  • Is INIM Pharma a private or public company?

    INIM Pharma is a Private company.

  • What is INIM Pharma’s current revenue?

    The current revenue for INIM Pharma is .

  • How much funding has INIM Pharma raised over time?

    INIM Pharma has raised $231K.

  • Who are INIM Pharma’s investors?

    Nanologica has invested in INIM Pharma.

  • When was INIM Pharma acquired?

    INIM Pharma was acquired on 20-Aug-2018.

  • Who acquired INIM Pharma?

    INIM Pharma was acquired by Vicore Pharma Holding.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process